Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Axis NIFTY Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited19.0387216273.9108
Domestic EquitiesDivi's Laboratories Limited8.214625951.6874
Domestic EquitiesDr. Reddy's Laboratories Limited8.0161124471.6466
Domestic EquitiesApollo Hospitals Enterprise Limited7.810721011.6044
Domestic EquitiesMax Healthcare Institute Limited7.3473151981.5092
Domestic EquitiesCipla Limited7.3260114911.5049
Domestic EquitiesLupin Limited5.558449531.1418
Domestic EquitiesFortis Healthcare Limited4.7825106440.9824
Domestic EquitiesTorrent Pharmaceuticals Limited4.351921360.8939
Domestic EquitiesLaurus Labs Limited4.259979480.8750
Domestic EquitiesAurobindo Pharma Limited3.861857090.7933
Domestic EquitiesGlenmark Pharmaceuticals Limited3.602230750.7399
Domestic EquitiesAlkem Laboratories Limited3.141511950.6453
Domestic EquitiesBiocon Limited2.5524145780.5243
Domestic EquitiesMankind Pharma Limited2.527623110.5192
Domestic EquitiesZydus Lifesciences Limited2.218351090.4557
Domestic EquitiesIPCA Laboratories Limited2.114328370.4343
Domestic EquitiesAbbott India Limited1.31251060.2696
Domestic EquitiesPiramal Pharma Limited0.9974126570.2049
Domestic EquitiesSyngene International Limited0.882438760.1813
Total 99.9164 20.5242
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd0.0818 0.0168
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.0018 0.0004
Total 0.0836 0.0172
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.